| 我国仿制药政策分析 |
| |
| 引用本文： | 陈敬,范平安,韩晟,林芳卉,史录文.我国仿制药政策分析[J].世界临床药物,2021(1). |
| |
| 作者姓名： | 陈敬 范平安 韩晟 林芳卉 史录文 |
| |
| 作者单位： | 北京大学药学院药事管理与临床药学系;北京大学医药管理国际研究中心 |
| |
| 基金项目： | 国家自然科学基金面上项目(71874006)。 |
| |
| 摘 要： | 本文收集了我国促进仿制药研发创新、供应保障、临床使用等方面的政策,以期为完善我国仿制药政策提出相应建议。我国的仿制药支持政策正逐步完善,相关措施逐步落地,但仍需进一步完善顶层设计,加强统筹协调,完善配套政策体系,加快政策实际落地,营造推进高质量仿制药替代使用的良好氛围。
|
| 关 键 词： | 仿制药 政策 激励 |
Analysis of generic drug policy in China |
| |
| CHEN Jing,FAN Pingan,HAN Sheng,LIN Fanghui,SHI Luwen.Analysis of generic drug policy in China[J].WORLD CLINICAL DRUGS,2021(1). |
| |
| Authors: | CHEN Jing FAN Pingan HAN Sheng LIN Fanghui SHI Luwen |
| |
| Institution: | (Department of Pharmacy Administration and Clinical Pharmacy,School of Pharmaceutical Sciences,Peking University,Beijing 100191,China;International Research Center for Medicinal Administration Peking University,Beijing 100191,China) |
| |
| Abstract: | The article collects policies on promoting innovation in generic drug、supplying guarantee、clinical using,in order to make corresponding suggestions for improving generic drug policy in China.The generic drug supporting policy in China is improving.The related measures are being phased in,but still need to improve top-level design,intensifies co-ordination,improve supporting policy system,speed up the actual implementation of policies,create a good atmosphere for promoting alternative using of high quality generic drug. |
| |
| Keywords: | generic drug policy incentive |
| 本文献已被 维普 等数据库收录！ |
|
